From: Identifying overlapping mutated driver pathways by constructing gene networks in cancer
Optimal gene sets | Gene number | Exclusivity | Coverage | P-value |
---|---|---|---|---|
CDKN2A, TP53, CDK4, RB1 | 4 | 82.4% | 83.3% | 2.64e-08 |
PTEN, PIK3CA, EGFR | 3 | 86.7% | 57.8% | 1.17e-05 |
CDK4, CDKN2B, RB1 | 3 | 95.7% | 73.3% | 7.62e-05 |
PIK3CA, PTEN, PIK3R1 | 3 | 96.0% | 53.3% | 1.17e-05 |
MDM4, QKI, TP53, MDM2 | 4 | 93.2% | 45.6% | 2.74e-05 |
MDM2, TP53, PIK3R1, CPT1B | 4 | 90.9% | 44.4% | 1.08e-04 |
CYP27B1, EGFR, NF1, PIK3R1 | 4 | 90.2% | 51.1% | 5.32e-04 |